CN104491360A - Traditional Chinese medicine composition for treating asthma and preparation method of traditional Chinese medicine composition - Google Patents
Traditional Chinese medicine composition for treating asthma and preparation method of traditional Chinese medicine composition Download PDFInfo
- Publication number
- CN104491360A CN104491360A CN201410734349.8A CN201410734349A CN104491360A CN 104491360 A CN104491360 A CN 104491360A CN 201410734349 A CN201410734349 A CN 201410734349A CN 104491360 A CN104491360 A CN 104491360A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- asthma
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of traditional Chinese medicines, and relates to a traditional Chinese medicine composition for treating asthma and a preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition comprises 8-14 parts of loquat leaves, 7-15 parts of thunberg fritillary bulb, 3-8 parts of mint, 6-12 parts of bitter almonds, 4-9 parts of flos farfarae, 8-16 parts of pinellia ternata, 3-8 parts of cortex albiziae, 2-6 parts of pogostemon cablin, 4-9 parts of rhizoma arisaematis, 4-10 parts of root bark of white mulberry, 3-7 parts of akebiaquinata, 5-9 parts of sedum lineare, 3-6 parts of vitex leaves and 4-10 parts of pachyrhizua angulatus. The preparation method of the traditional Chinese medicine composition comprises the following steps: respectively crushing the traditional Chinese medicine materials by using a crushing machine, and uniformly mixing, thereby obtaining the traditional Chinese medicine composition for treating asthma. The traditional Chinese medicine composition for treating asthma, which is provided by the invention, has a very good treatment effect in treating asthma diseases, and the total treatment rate is greater than 70%.
Description
Technical field
The invention belongs to the field of Chinese medicines, relate to a kind of Chinese medicine composition and preparation method thereof, particularly relate to Chinese medicine composition for the treatment of asthma and preparation method thereof.
Background technology
Asthma is the chronic airway inflammation disease participated in by various kinds of cell and cellular component.The clinical symptoms of asthma for panting, tight, the uncomfortable in chest and asthma of gas.The ictal expiratory dyspnea with wheezing sound, night and outbreak in morning or increase the weight of to be the important clinical feature of asthma.Also there is the asthma that is not true to type not having wheezing symptoms clinically, patient can show as ictal cough, uncomfortable in chest and other symptoms.The symptoms such as asthma in acute attack stage refers to pant, out of breath, uncomfortable in chest or cough occur suddenly or exacerbation of symptoms, reduce with expiratory gas flow, often because of caused by the stimulus object such as contact allergen or malpractice.Asthma reason is very complicated, mostly on the basis of heredity, is subject to some factor of inside and outside.Such as: irritated, infect, overworked, Nervous and Mental Factors and exciting.Tracheal smooth muscle spasm during outbreak, myxedema, thus produce uncomfortable in chest, cough with copious phlegm not easily expectoration, pallor purple lip, to be nervously in a cold sweat, dyspnea is with symptoms such as wheezing sounds.
Summary of the invention
The technical problem solved: asthma is as a kind of disease being comparatively difficult to cure, and the curative effect of a lot of Chinese crude drug treatment patient asthma disease is poor.The asthma situation of patient can time have recurrence, the object of this invention is to provide a kind of can effective Chinese medicine composition of curing asthma disease and preparation method thereof.
Technical scheme: the Chinese medicine composition that the invention discloses treatment asthma, the Chinese medicine composition of described treatment asthma comprises the composition of following weight parts:
Folium Eriobotryae 8-14 part, Bulbus Fritillariae Thunbergii 7-15 part,
Herba Menthae 3-8 part, Semen Armeniacae Amarum 6-12 part,
Flos Farfarae 4-9 part, Rhizoma Pinelliae 8-16 part,
Cortex Albiziae 3-8 part, Herba Pogostemonis 2-6 part,
Rhizoma Arisaematis 4-9 part, Cortex Mori 4-10 part,
Caulis Akebiae 3-7 part, Herba Sedi Linearis 5-9 part,
Folium Viticis Negundo 3-6 part, Pachyrhizua angulatus 4-10 part.
Preferably, the Chinese medicine composition of described treatment asthma, comprises the composition of following weight parts:
Folium Eriobotryae 10-12 part, Bulbus Fritillariae Thunbergii 9-13 part,
Herba Menthae 5-6 part, Semen Armeniacae Amarum 8-10 part,
Flos Farfarae 5-8 part, Rhizoma Pinelliae 11-14 part,
Cortex Albiziae 4-6 part, Herba Pogostemonis 3-5 part,
Rhizoma Arisaematis 6-8 part, Cortex Mori 5-8 part,
Caulis Akebiae 5-6 part, Herba Sedi Linearis 6-8 part,
Folium Viticis Negundo 4-5 part, Pachyrhizua angulatus 6-9 part.
Preferred further, the Chinese medicine composition of described treatment asthma, comprises the composition of following weight parts:
Folium Eriobotryae 11 parts, Bulbus Fritillariae Thunbergii 11 parts,
Herba Menthae 6 parts, Semen Armeniacae Amarum 9 parts,
Flos Farfarae 7 parts, the Rhizoma Pinelliae 12 parts,
Cortex Albiziae 5 parts, Herba Pogostemonis 4 parts,
Rhizoma Arisaematis 7 parts, Cortex Mori 6 parts,
Caulis Akebiae 5 parts, Herba Sedi Linearis 7 parts,
Folium Viticis Negundo 4 parts, Pachyrhizua angulatus 8 parts.
The preparation method of the Chinese medicine composition for the treatment of asthma, step is as follows:
Get that Folium Eriobotryae is 8-14 part, Bulbus Fritillariae Thunbergii is 7-15 part, Herba Menthae is 3-8 part, Semen Armeniacae Amarum is 6-12 part, Flos Farfarae is 4-9 part, the Rhizoma Pinelliae is 8-16 part, Cortex Albiziae is 3-8 part, Herba Pogostemonis is 2-6 part, Rhizoma Arisaematis is 4-9 part, Cortex Mori is 4-10 part, Caulis Akebiae is 3-7 part, Herba Sedi Linearis is 5-9 part, Folium Viticis Negundo is 3-6 part, Pachyrhizua angulatus is 4-10 part by weight, above-mentioned Chinese crude drug is pulverized with pulverizer respectively, be crushed to mix homogeneously, for treating the Chinese medicine composition of asthma.
The preparation method of the Chinese medicine composition of described treatment asthma, is crushed to 200 order to 300 orders by Chinese crude drug pulverizer in preparation method.
Beneficial effect: the Chinese crude drug such as Folium Eriobotryae, Bulbus Fritillariae Thunbergii, Herba Menthae, Semen Armeniacae Amarum has certain curative effect on treatment asthma disease, the Chinese medicine composition for the treatment of asthma of the present invention is on the Chinese crude drug basis of above-mentioned conventional therapy asthma, add Herba Sedi Linearis, Folium Viticis Negundo and Pachyrhizua angulatus, improve the curative effect of the traditional Chinese medicine composition for treating asthma of preparation significantly, the complete cure rate of asthma disease, more than 70%, has possessed very good treatment characteristic.
Detailed description of the invention
Embodiment 1
Get that Folium Eriobotryae is 14 parts, Bulbus Fritillariae Thunbergii is 15 parts, Herba Menthae is 3 parts, Semen Armeniacae Amarum is 12 parts, Flos Farfarae is 4 parts, the Rhizoma Pinelliae is 16 parts, Cortex Albiziae is 8 parts, Herba Pogostemonis is 6 parts, Rhizoma Arisaematis is 9 parts, Cortex Mori is 10 parts, Caulis Akebiae is 7 parts, Herba Sedi Linearis is 5 parts, Folium Viticis Negundo is 3 parts, Pachyrhizua angulatus is 10 parts by weight, above-mentioned Chinese crude drug is pulverized with pulverizer respectively, be crushed to mix homogeneously, for treating the Chinese medicine composition of asthma.
Embodiment 2
Get that Folium Eriobotryae is 8 parts, Bulbus Fritillariae Thunbergii is 7 parts, Herba Menthae is 8 parts, Semen Armeniacae Amarum is 6 parts, Flos Farfarae is 9 parts, the Rhizoma Pinelliae is 8 parts, Cortex Albiziae is 3 parts, Herba Pogostemonis is 2 parts, Rhizoma Arisaematis is 4 parts, Cortex Mori is 4 parts, Caulis Akebiae is 3 parts, Herba Sedi Linearis is 9 parts, Folium Viticis Negundo is 6 parts, Pachyrhizua angulatus is 4 parts by weight, above-mentioned Chinese crude drug is pulverized with pulverizer respectively, be crushed to mix homogeneously, for treating the Chinese medicine composition of asthma.
Embodiment 3
Get that Folium Eriobotryae is 12 parts, Bulbus Fritillariae Thunbergii is 9 parts, Herba Menthae is 6 parts, Semen Armeniacae Amarum is 10 parts, Flos Farfarae is 8 parts, the Rhizoma Pinelliae is 14 parts, Cortex Albiziae is 6 parts, Herba Pogostemonis is 5 parts, Rhizoma Arisaematis is 8 parts, Cortex Mori is 8 parts, Caulis Akebiae is 6 parts, Herba Sedi Linearis is 8 parts, Folium Viticis Negundo is 5 parts, Pachyrhizua angulatus is 9 parts by weight, above-mentioned Chinese crude drug is pulverized with pulverizer respectively, be crushed to mix homogeneously, for treating the Chinese medicine composition of asthma.
Embodiment 4
Get that Folium Eriobotryae is 10 parts, Bulbus Fritillariae Thunbergii is 13 parts, Herba Menthae is 5 parts, Semen Armeniacae Amarum is 8 parts, Flos Farfarae is 5 parts, the Rhizoma Pinelliae is 11 parts, Cortex Albiziae is 4 parts, Herba Pogostemonis is 3 parts, Rhizoma Arisaematis is 6 parts, Cortex Mori is 5 parts, Caulis Akebiae is 5 parts, Herba Sedi Linearis is 6 parts, Folium Viticis Negundo is 4 parts, Pachyrhizua angulatus is 6 parts by weight, above-mentioned Chinese crude drug is pulverized with pulverizer respectively, be crushed to mix homogeneously, for treating the Chinese medicine composition of asthma.
Embodiment 5
Get that Folium Eriobotryae is 11 parts, Bulbus Fritillariae Thunbergii is 11 parts, Herba Menthae is 6 parts, Semen Armeniacae Amarum is 9 parts, Flos Farfarae is 7 parts, the Rhizoma Pinelliae is 12 parts, Cortex Albiziae is 5 parts, Herba Pogostemonis is 4 parts, Rhizoma Arisaematis is 7 parts, Cortex Mori is 6 parts, Caulis Akebiae is 5 parts, Herba Sedi Linearis is 7 parts, Folium Viticis Negundo is 4 parts, Pachyrhizua angulatus is 8 parts by weight, above-mentioned Chinese crude drug is pulverized with pulverizer respectively, be crushed to mix homogeneously, for treating the Chinese medicine composition of asthma.
Comparative example 1
Get that Folium Eriobotryae is 14 parts, Bulbus Fritillariae Thunbergii is 15 parts, Herba Menthae is 3 parts, Semen Armeniacae Amarum is 12 parts, Flos Farfarae is 4 parts, the Rhizoma Pinelliae is 16 parts, Cortex Albiziae is 8 parts, Herba Pogostemonis is 6 parts, Rhizoma Arisaematis is 9 parts, Cortex Mori is 10 parts, Caulis Akebiae is 7 parts, Folium Viticis Negundo is 3 parts, Pachyrhizua angulatus is 10 parts by weight, above-mentioned Chinese crude drug is pulverized with pulverizer respectively, be crushed to mix homogeneously, for treating the Chinese medicine composition of asthma.
Comparative example 2
Get that Folium Eriobotryae is 14 parts, Bulbus Fritillariae Thunbergii is 15 parts, Herba Menthae is 3 parts, Semen Armeniacae Amarum is 12 parts, Flos Farfarae is 4 parts, the Rhizoma Pinelliae is 16 parts, Cortex Albiziae is 8 parts, Herba Pogostemonis is 6 parts, Rhizoma Arisaematis is 9 parts, Cortex Mori is 10 parts, Caulis Akebiae is 7 parts by weight, above-mentioned Chinese crude drug is pulverized with pulverizer respectively, be crushed to mix homogeneously, for treating the Chinese medicine composition of asthma.
The Chinese medicine composition boiling water of embodiment 1 to 5 and comparative example 1 and 2 is decocted 40min, the weight ratio of boiling water and Chinese medicine composition is 5:1, filter after decocting, asthmatic patient is divided into 7 groups, often organizing patient numbers is 30 people, takes the decoction liquor 100mL of Chinese medicine composition every day, 20 days, observe the asthma disease treatment situation of asthmatic patient, concrete cure rate is as follows:
| Complete cure rate | Remarkable effective percentage | Complete inefficiency | |
| Embodiment 1 | 76% | 22% | 2% |
| Embodiment 2 | 78% | 20% | 2% |
| Embodiment 3 | 84% | 16% | 0 |
| Embodiment 4 | 86% | 12% | 0 |
| Embodiment 5 | 92% | 8% | 0 |
| Comparative example 1 | 64% | 24% | 12% |
| Comparative example 2 | 36% | 30% | 34% |
Herba Sedi Linearis, Folium Viticis Negundo, the curative effect of Pachyrhizua angulatus three kinds of Chinese medicines on the treatment asthma of Chinese medicine composition of the present invention have very large impact, as can be seen from comparing result, do not add in the Chinese medicine of Herba Sedi Linearis and Folium Viticis Negundo and Pachyrhizua angulatus, its complete cure rate only has 36%, significantly lower than the therapeutic effect of the Chinese medicine composition of embodiment 1 to 5.
Claims (5)
1. treat the Chinese medicine composition of asthma, it is characterized in that the Chinese medicine composition of described treatment asthma comprises the composition of following weight parts:
Folium Eriobotryae 8-14 part, Bulbus Fritillariae Thunbergii 7-15 part,
Herba Menthae 3-8 part, Semen Armeniacae Amarum 6-12 part,
Flos Farfarae 4-9 part, Rhizoma Pinelliae 8-16 part,
Cortex Albiziae 3-8 part, Herba Pogostemonis 2-6 part,
Rhizoma Arisaematis 4-9 part, Cortex Mori 4-10 part,
Caulis Akebiae 3-7 part, Herba Sedi Linearis 5-9 part,
Folium Viticis Negundo 3-6 part, Pachyrhizua angulatus 4-10 part.
2. the Chinese medicine composition for the treatment of asthma according to claim 1, is characterized in that the Chinese medicine composition of described treatment asthma comprises the composition of following weight parts:
Folium Eriobotryae 10-12 part, Bulbus Fritillariae Thunbergii 9-13 part,
Herba Menthae 5-6 part, Semen Armeniacae Amarum 8-10 part,
Flos Farfarae 5-8 part, Rhizoma Pinelliae 11-14 part,
Cortex Albiziae 4-6 part, Herba Pogostemonis 3-5 part,
Rhizoma Arisaematis 6-8 part, Cortex Mori 5-8 part,
Caulis Akebiae 5-6 part, Herba Sedi Linearis 6-8 part,
Folium Viticis Negundo 4-5 part, Pachyrhizua angulatus 6-9 part.
3. the Chinese medicine composition for the treatment of asthma according to claim 1, is characterized in that the Chinese medicine composition of described treatment asthma comprises the composition of following weight parts:
Folium Eriobotryae 11 parts, Bulbus Fritillariae Thunbergii 11 parts,
Herba Menthae 6 parts, Semen Armeniacae Amarum 9 parts,
Flos Farfarae 7 parts, the Rhizoma Pinelliae 12 parts,
Cortex Albiziae 5 parts, Herba Pogostemonis 4 parts,
Rhizoma Arisaematis 7 parts, Cortex Mori 6 parts,
Caulis Akebiae 5 parts, Herba Sedi Linearis 7 parts,
Folium Viticis Negundo 4 parts, Pachyrhizua angulatus 8 parts.
4. treat the preparation method of the Chinese medicine composition of asthma, it is characterized in that, the preparation method step of the Chinese medicine composition of described treatment asthma is as follows:
Get that Folium Eriobotryae is 8-14 part, Bulbus Fritillariae Thunbergii is 7-15 part, Herba Menthae is 3-8 part, Semen Armeniacae Amarum is 6-12 part, Flos Farfarae is 4-9 part, the Rhizoma Pinelliae is 8-16 part, Cortex Albiziae is 3-8 part, Herba Pogostemonis is 2-6 part, Rhizoma Arisaematis is 4-9 part, Cortex Mori is 4-10 part, Caulis Akebiae is 3-7 part, Herba Sedi Linearis is 5-9 part, Folium Viticis Negundo is 3-6 part, Pachyrhizua angulatus is 4-10 part by weight, above-mentioned Chinese crude drug is pulverized with pulverizer respectively, be crushed to mix homogeneously, for treating the Chinese medicine composition of asthma.
5. the preparation method of the Chinese medicine composition for the treatment of asthma according to claim 4, is characterized in that, in the preparation method of the Chinese medicine composition of described treatment asthma, Chinese crude drug pulverizer is crushed to 200 order to 300 orders.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410734349.8A CN104491360A (en) | 2014-12-08 | 2014-12-08 | Traditional Chinese medicine composition for treating asthma and preparation method of traditional Chinese medicine composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410734349.8A CN104491360A (en) | 2014-12-08 | 2014-12-08 | Traditional Chinese medicine composition for treating asthma and preparation method of traditional Chinese medicine composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104491360A true CN104491360A (en) | 2015-04-08 |
Family
ID=52932874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410734349.8A Pending CN104491360A (en) | 2014-12-08 | 2014-12-08 | Traditional Chinese medicine composition for treating asthma and preparation method of traditional Chinese medicine composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104491360A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109170411A (en) * | 2018-08-13 | 2019-01-11 | 佛山市三水区嘉华化学研究院（普通合伙） | A kind of clearing lung-heat fall fire beverage and preparation method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE202010013170U1 (en) * | 2010-12-21 | 2011-04-28 | Yangsen Biotechnology Co., Ltd., Bei-Tou | Composition of essential oils for the treatment and / or prevention of respiratory diseases |
| CN102475789A (en) * | 2010-11-23 | 2012-05-30 | 鲜丹科 | Fei Kang Ling |
| CN102895443A (en) * | 2012-10-13 | 2013-01-30 | 袁小芬 | Chinese medicine for treating asthma |
| CN103191331A (en) * | 2013-04-18 | 2013-07-10 | 刘冰甜 | Traditional Chinese medicine composition for treating bronchial asthma in remission stage |
| CN103830694A (en) * | 2012-11-24 | 2014-06-04 | 高炳良 | Medicinal liquor for treating cough and wheeze |
| CN103933435A (en) * | 2014-04-20 | 2014-07-23 | 文成县刀锋科技有限公司 | Traditional Chinese medicine preparation for effectively treating dry cough |
-
2014
- 2014-12-08 CN CN201410734349.8A patent/CN104491360A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102475789A (en) * | 2010-11-23 | 2012-05-30 | 鲜丹科 | Fei Kang Ling |
| DE202010013170U1 (en) * | 2010-12-21 | 2011-04-28 | Yangsen Biotechnology Co., Ltd., Bei-Tou | Composition of essential oils for the treatment and / or prevention of respiratory diseases |
| CN102895443A (en) * | 2012-10-13 | 2013-01-30 | 袁小芬 | Chinese medicine for treating asthma |
| CN103830694A (en) * | 2012-11-24 | 2014-06-04 | 高炳良 | Medicinal liquor for treating cough and wheeze |
| CN103191331A (en) * | 2013-04-18 | 2013-07-10 | 刘冰甜 | Traditional Chinese medicine composition for treating bronchial asthma in remission stage |
| CN103933435A (en) * | 2014-04-20 | 2014-07-23 | 文成县刀锋科技有限公司 | Traditional Chinese medicine preparation for effectively treating dry cough |
Non-Patent Citations (3)
| Title |
|---|
| 白月双等: "盛丽先老师运用三拗汤治疗小儿呼吸系统疾病经验", 《中医儿科杂志》 * |
| 蔡铁如等: "《袁长津病证辨治实录》", 30 June 2014 * |
| 韩淑花等: "《甘露消毒丹》", 31 January 2013 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109170411A (en) * | 2018-08-13 | 2019-01-11 | 佛山市三水区嘉华化学研究院（普通合伙） | A kind of clearing lung-heat fall fire beverage and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104382994A (en) | Glycyrrhiza plant fermentation liquor and preparation method thereof | |
| CN102845574A (en) | Dragon boat festival tea and its making method | |
| CN104940759A (en) | Ointment paste for treating wind cold and cough | |
| CN104491360A (en) | Traditional Chinese medicine composition for treating asthma and preparation method of traditional Chinese medicine composition | |
| CN1879715A (en) | Chinese medicine for wax therapy of cervical spondylosis | |
| CN103830694A (en) | Medicinal liquor for treating cough and wheeze | |
| CN102225118A (en) | Blood-activating wind-dispelling liquid | |
| CN102764377B (en) | Chinese herba preparation used for treating epilepsy | |
| CN101856488A (en) | Chinese medicament for treating tracheitis | |
| CN104435644A (en) | Traditional Chinese medicine preparation for treating asthma as well as preparation method and application of traditional Chinese medicine preparation | |
| CN103599506A (en) | Traditional Chinese medicine for treating urticaria | |
| CN102000239A (en) | Traditional Chinese medicine for treating cough | |
| CN105770528A (en) | Chinese medicinal composition for treating asthma of heat type and preparation method thereof | |
| CN105267937A (en) | Wine for cold, cool and cough | |
| CN105687484A (en) | Traditional Chinese medicinal liquor for treating arteriosclerosis and preparation method of traditional Chinese medicinal liquor | |
| CN103768384A (en) | Traditional Chinese medicinal composition for treating emphysema and preparation method of composition | |
| CN103933398A (en) | Traditional Chinese medicine compositionfor treating chronic pharyngitis | |
| CN104367735A (en) | Traditional Chinese medicine composition for treating asthma | |
| CN104689085A (en) | Buccal tablet for treating dry cracked lip | |
| CN104107294A (en) | Traditional Chinese medicine preparation used for treating chronic bronchitis, and preparation method and application thereof | |
| CN104138438A (en) | Exogenous cough treatment medicine | |
| CN104383371A (en) | Traditional Chinese medicinal composition for treating pityriasis rosea | |
| CN103893439A (en) | Traditional Chinese medicine composition for treating rhinitis and preparation method thereof | |
| CN103316211A (en) | Traditional Chinese medicine composition for treating emphysema and preparation method thereof | |
| CN102406740A (en) | Pure Chinese traditional medicine composition for treating poultry tissues trichomoniasis and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150408 |
|
| RJ01 | Rejection of invention patent application after publication |